← All companies
Monte Rosa Therapeutics, Inc.
GLUE - CIK 0001826457
Market cap$1.39 B
Rank#2396
SEC filings352
The table below shows Monte Rosa Therapeutics, Inc.'s income statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - |
| Cost of revenue | - | - | - | - | - | - |
| Gross profit | - | - | - | - | - | - |
| R&D | $44.07M | $36.68M | $30.65M | $32.19M | $27.62M | $28.05M |
| SG&A |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.